SINOPHARM GROUP CO. LTD. News

Express News | Johnson & Johnson, Bristol-Myers Squibb lose lawsuit in US drug price negotiation process

BreakingsApr 30 06:09

Express News | National Centralized Drug Procurement (Insulin Special Continuation) Selection Results Announced and Implemented in May

BreakingsApr 28 16:49

Express News | The State Organization Drug Joint Procurement Office reported on interviews with bidding companies for some varieties of drugs collected by the State Organization with abnormal prices

BreakingsApr 28 16:17

Express News | Huiyu Pharmaceutical: Benzenesulfonium atracurium injection obtained marketing approval in the UK

BreakingsApr 28 15:46

Express News | Ganli Pharmaceutical: The company participated in the national centralized drug procurement (insulin special continuation) to win the bid

BreakingsApr 23 18:21

Express News | Tonghua Dongbao: Multiple specification products to be selected for centralized procurement

BreakingsApr 23 17:11

Express News | Sinopharm Hyundai: Subsidiary drug injectable ceftriaxone passes generic drug consistency evaluation

BreakingsApr 19 16:19

Express News | Sinopharm Holdings: Sinopharm Xinguang 4K defogging endoscope system approved for listing

BreakingsApr 18 17:23

Express News | Chenxi Health completed a round A financing round of over 100 million yuan, and Sinopharm Holdings accelerates the construction of new quality productivity

BreakingsApr 10 09:26

Express News | Sinopharm Hyundai: The holding subsidiary received a notice of approval for the marketing application of chemical raw materials

BreakingsApr 9 16:39

Express News | Tiantan Biology: Human Prothrombin Complex Receives Drug Clinical Trial Approval Notice

BreakingsApr 3 18:35

Express News | Citigroup: Raise Sinopharm's target price to HK$30 to maintain “buy” rating

BreakingsMar 27 14:25

SINOPHARM GROUP CO. LTD. To Go Ex-Dividend On June 17th, 2024 With 0.12623 USD Dividend Per Share

March 26th - $SINOPHARM GROUP CO. LTD.(SHTDF.US)$ is trading ex-dividend on June 17th, 2024. Shareholders of record on June 18th, 2024 will receive 0.12623 USD dividend per share on August 13th, 2

Futu NewsMar 26 08:45

Express News | Bristol-Myers Squibb CEO Brooks: Continuing to optimize the pricing and payment system for innovative drugs

BreakingsMar 25 23:48

Express News | Sinopharm Holdings' revenue for the full year of 2023 was 596.6 billion yuan

BreakingsMar 25 06:18

Express News | Fuling joins hands with Sinopharm Taiji to build an intelligent manufacturing center with a production capacity of 30 billion

BreakingsMar 14 22:59

Express News | Chongqing City and Sinopharm Group sign strategic cooperation framework agreement

BreakingsMar 14 22:51

Express News | Sinopharm Holdings: Sinopharm's net profit in 2023 was 1,599 billion yuan, up 7.57% year on year

BreakingsMar 14 20:24

Express News | Sinopharm Holdings (01099.HK): In 2023, it achieved operating income of RMB 75.477 billion, up 2.77% year on year; net profit of RMB 1,958 billion, up 10.54% year on year; net profit attributable to shareholders of listed companies was RMB 1,599 billion,

BreakingsMar 14 19:29

Express News | Sinopharm agrees: Guokong Guangzhou and Xiangle Consulting sign a strategic cooperation agreement

BreakingsMar 7 19:28